The report "Surgical Sealants and Adhesives Market by Product (Natural (Fibrin, Collagen, Gelatin), Synthetic (Hydrogel)), Indication (Tissue Sealing, Tissue Engineering), Application (CNS, Cardiovascular, Cosmetic Surgery), End User - Global Forecast to 2025", is expected to reach USD 2.8 billion in 2025 from USD 1.9 billion in 2020, at a CAGR of 8.4% during the forecast period. With growing concerns regarding the effective management of blood loss in patients during surgeries and trauma, surgical sealants and adhesives have become an integral part of medical procedures. Also, the growing prevalence and incidence rates of various disorders such as obesity and CVDs; increasing incidence of trauma; growth in the number of accidents and sports-related injuries, which has led to an increase in surgical procedures being performed across the globe are factors driving the market growth. Better cosmetic outcomes are also increasing the adoption of surgical sealants and adhesives in cosmetic procedures across the globe. The growing prominence of adhesive dentistry also offers significant growth opportunities for players operating in this space.
Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=38230314
Key Player
The prominent players in this market are Baxter International, Inc. (US), CryoLife, Inc. (US), Becton, Dickinson and Company [C.R Bard (US)], Ethicon, Inc. (US), Cardinal Health, Inc. (US), B. Braun Melsungen AG (Germany), Integra Lifesciences Holdings Corporation (US), Medline Industries, Inc. (US), Adhezion Biomedical, LLC (US), Tricol Biomedical, Inc. (US), Vivostat A/S (Denmark), Advanced Medical Solutions Group plc (UK), Stryker Corporation (US), CSL Limited (Australia), Ocular Therapeutix, Inc. (US), MicroVal (France), GEM Srl (Italy), Hemostasis, LLC (US), Péters Surgical (France), and Tissuemed Ltd (UK).
Johnson & Johnson (Ethicon, Inc.) (US) was the leading player in the surgical sealants and adhesives market in 2019. The company has a strong brand value as well as an established geographic presence. It offers a strong and broad product portfolio for surgical sealants and adhesives, which serves as an important factor for its large market share. Its flagship sealants and hemostatic products such as EVICEL, SURGICEL, EVARREST, SURGIFLOW, and SURGIFOAM series are some of the leading brands in the global biosurgery market. The company has reported revenue growth of ~ 5-8% in its biosurgical products segment between 2018 and 2019. The growth of this segment is mainly driven by the company’s wide presence in the APAC market and continuous growth in the US market. It further focuses on increasing its presence in this market through continuous R&D activities to provide technologically advanced solutions to customers.
The natural/biological sealants and adhesives segment is expected to account for the largest share of the surgical sealants market, by product.
By product, the market is segmented into natural/biological sealants and adhesives and synthetic & semisynthetic sealants and adhesives. The natural/biological sealants and adhesives segment accounted for the largest share of the market in 2019. This segment is further segmented into polypeptide protein-based sealants and adhesives and polysaccharide-based sealants and adhesives. The large share of natural/biological sealants and adhesives segment can be attributed to the fact that sealants derived from natural polymers provide superior biocompatibility, reduced immune response, and in vivo degradability as compared to synthetic sealants; and are used to repair injured tissues and reinforce surgical wounds, thus having replaced common suturing techniques.
The tissue engineering segment is expected to grow at the highest CAGR during the forecast period.
Based on indication, the surgical sealants market is segmented into tissue sealing, surgical hemostasis, and tissue engineering. The tissue engineering segment is projected to witness the highest growth in the market during the forecast period. This is due to the growing need for tissue regeneration in cases of skin injuries or burn injuries, along with the increasing number of cosmetic surgeries taking place across the globe.
Inquiry Before Buying @
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=38230314
The cosmetic surgery segment is expected to grow at the highest CAGR during the forecast period.
Based on application, the surgical sealants market is segmented into cardiovascular surgery, general surgery, CNS surgery, pulmonary surgery, ophthalmic surgery, orthopedic surgery, cosmetic surgery, urological surgery, and other applications. The cosmetic surgery segment is projected to witness the highest growth in the market during the forecast period. This is due to the increasing adoption of tissue sealants and adhesives for cosmetic procedures and burn treatment surgeries. It is further set to increase with the increasing number of facial cosmetic surgeries, increasing cases of skin injuries, growing incidence of burn injuries, and an increasing number of breast cancer patients undergoing mastectomy and breast reconstruction procedures across the globe.
Hospitals to account for the largest share of the surgical sealants market, by end user.
On the basis of end users, the market is segmented into hospitals, clinics, and other end users (ambulatory surgery centers, burn care centers, and research institutes). The hospital segment accounted for the largest share of the market in 2019. This is primarily attributed to the increasing number of surgeries taking place across the globe due to the rising geriatric population and the incidence of various diseases. Moreover, the increasing need to control blood loss and achieve efficient hemostasis and wound closure in trauma cases, injuries, or surgical procedures is leading to their rising adoption by surgeons. The low cost of these products along with their ease of use and lower risk of complications, offer significant advantages, further supporting market growth.
North America to dominate the surgical sealants and adhesives market during the forecast period
In 2019, North America dominated the global surgical sealants and adhesives market, followed by Europe. The large share of North America can be attributed to the significant growth opportunities for players operating in the surgical sealants and adhesives market owing to the presence of many large hospitals and an increasing number of surgical procedures in this region. Moreover, a number of major global players are based in the US, owing to which the US is a center for innovation in the surgical sealants and adhesives market.
View detailed Table of Content here@
https://www.marketsandmarkets.com/Market-Reports/surgical-sealants-adhesives-market-38230314.html
Recent Developments:
- In 2019, Johnson & Johnson (Ethicon, Inc.) launched VISTASEAL Fibrin Sealant (Human) to manage bleeding during surgery.
- In 2019, CSL opened its new global headquarters in Melbourne, Australia, for the fostering and supporting of collaborations between academic biomedical research and industry, creating important linkages in the translation for new medicines for unmet medical needs.
- In 2019, AMS acquired Sealantis, an Israeli-based medical device company with a patent-protected alga-mimetic sealant technology platform that has a wide range of potential surgical indications under development. This helped AMS strengthen its presence with a technology platform and delivery systems that have significant potential across a range of applications in the high-margin internal surgery market.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/surgical-sealants-adhesives-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/surgical-sealants-adhesives.asp
Related Report:
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek